NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer Aug 7, 2023
New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody Aug 1, 2023
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia Jul 21, 2023